Navigation Links
Immune system implicated in prematurity complication
Date:3/19/2012

Despite advances in neonatal care, necrotizing enterocolitis (NEC) the most common gastrointestinal emergency in premature infants continues to be a deadly disease.

"We haven't made a lot of progress in identifying babies early who may be at risk for NEC, preventing it or treating it," said Jrn-Hendrik Weitkamp, M.D., a neonatologist and assistant professor of Pediatrics at Monroe Carell Jr. Children's Hospital at Vanderbilt.

Now, Weitkamp and his colleagues have discovered that disruptions in immune system regulation not previously considered to be important in NEC pathophysiology may play a role in the disease. The findings, reported in the journal Gut, suggest a new target for therapeutic interventions for NEC.

NEC is an inflammatory disease that kills intestinal tissue. Premature babies, and particularly those who have early formula feedings (breast milk has protective properties), are at increased risk for developing NEC.

About 40 percent of babies with NEC require surgery to remove dead bowel tissue and half of these babies do not survive. NEC survivors suffer long-term complications including bowel-related problems and impairments in motor and cognitive function.

Weitkamp wanted to explore whether differences in immune system regulation particularly in the "adaptive" immune response mediated by B cells and T cells might play a role in NEC. This type of cellular immunity was not considered important in the early neonatal period because it takes time to develop, and because it was not found in mouse models, Weitkamp said. But he knew from other studies that immune responses in newborn mice are not identical to immune responses in newborn humans.

Weitkamp and his colleagues turned to stored human intestinal tissue samples that had been surgically removed from preterm babies diagnosed with NEC or other intestinal diseases. They found high levels of T cells called T regulatory (Treg) cells in the intestine of premature infants, which was surprising given the lack of these cells in the gut of newborn mice. Treg cells suppress the immune response and are critical for keeping the immune system in balance, preventing harmful inflammation.

Because of limitations related to Treg cell detection in stored tissue samples, the investigators collected fresh intestinal tissue samples from babies having surgery for NEC and for non-NEC problems, during or immediately after surgery.

Using multiple cellular "markers" and flow cytometry to identify the Treg cells, they confirmed that premature babies have an abundance of Treg cells in the intestines. Babies with NEC had about 60 percent fewer Treg cells than babies with non-NEC problems.

The investigators also detected increased expression of inflammatory cytokines (immune system signaling molecules) particularly those that suppress Treg cell development in the NEC tissue samples. And in assays of cell function, they found that the Treg cells suppressed cytokine production by and proliferation of T cells.

Follow-up studies on tissue samples from infants who had a second surgery suggest that the reduction in Treg cells is not because of an immune system defect in the babies.

"We believe that the T regulatory cells we've identified are in fact functional Treg cells and that they are down-regulated at the time of NEC," Weitkamp said. "Our studies challenge the dogma that cellular immunity is not important in the immediate neonatal period or in the pathophysiology of NEC."

Now, Weitkamp and his colleagues including neonatology fellow Joann Romano-Keeler, M.D., are studying the intestinal microbiome the collection of microbes colonizing the gut in the surgically removed samples.

"We know that the microbiome and the immune system are important in shaping each other," Weitkamp said.

"We need to understand exactly how that works and which components typically found in human milk such as certain vitamins, prebiotics and probiotics are important for healthy microbiome and healthy immune system development."

Such components, he said, might become the basis for interventions to prevent the development of NEC.

Vanderbilt's collaborative environment and the support of colleagues in Pediatric Surgery, Pathology and Neonatology made the collection of fresh surgical tissue samples possible, Weitkamp said.


'/>"/>

Contact: Leigh MacMillan
leigh.macmillan@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related biology news :

1. New insight into mechanisms behind autoimmune diseases suggests a potential therapy
2. UCI-led study uncovers how Salmonella avoids the bodys immune response
3. U of Alberta researcher steps closer to understand autoimmune diseases
4. Depression could be evolutionary byproduct of immune system
5. Secrets of immune response illuminated in new study
6. Human immune cells react sensitively to stress
7. Stealthy leprosy pathogen evades critical vitamin D-dependent immune response
8. Aiding cancer therapy by mathematically modeling tumor-immune interactions
9. UCSF team uncovers how immune cells move against invaders
10. La Jolla Institute researchers identify pivotal immune cell in Type 1 diabetes in humans
11. Researchers discover novel anti-viral immune pathway in the mosquito
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: